BK polyomavirus (BKPyV) often reactivates after kidney transplantation, causing BKPyV-associated nephropathy (BKPyVAN) in 1%-10% of cases with a potential detrimental effect on allograft survival. Kidney transplant recipients are regularly screened for BKPyV DNA in plasma. As this strategy may not always reduce the risk of BKPyVAN, other predictive markers are needed. To evaluate the role of pretransplant BKPyV-specific antibody, 210 kidney transplant recipients and 130 donors were screened for BKPyV DNA and BKPyV-specific antibodies. We found that the donor BKPyV immunoglobulin G (IgG) seroprevalence and antibody level were strongly associated with BKPyV-DNAemia and BKPyVAN, although multivariant analysis found the presence of anti-BKPyV-specific antibodies as a predictive factor only for BKPyV-DNAemia. The pretransplant recipient status had no effect on posttransplant BKPyV-DNAemia and BKVAN. BKPyV IgG levels remained stable in BKPyV-negative recipients during 1-year follow-up, while a considerable increase was observed in BKPyV-positive patients. The presence of anti-BKPyV-specific antibodies in kidney allograft donors is a good and reliable predictive marker for posttransplant BKPyV replication with relevance to risk stratification in transplant recipients.

Department of Genetics and Microbiology Faculty of Science Charles University Prague Czechia

Department of Nephrology Transplant Centre Institute for Clinical and Experimental Medicine Prague Czechia

National Reference Laboratory for Papillomaviruses and Polyomaviruses Institute of Hematology and Blood Transfusion Prague Czechia

000      

00000naa a2200000 a 4500

001      

bmc22025161

003      

CZ-PrNML

005      

20221031100530.0

007      

ta

008      

221017s2022 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3389/fimmu.2022.929946 $2 doi

035    __

$a (PubMed)35967393

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Saláková, Martina $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czechia

245    10

$a Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia / $c M. Saláková, V. Ludvíková, E. Hamšíková, M. Kolářová, V. Šroller, O. Viklický, M. Wohlfahrtová

520    9_

$a BK polyomavirus (BKPyV) often reactivates after kidney transplantation, causing BKPyV-associated nephropathy (BKPyVAN) in 1%-10% of cases with a potential detrimental effect on allograft survival. Kidney transplant recipients are regularly screened for BKPyV DNA in plasma. As this strategy may not always reduce the risk of BKPyVAN, other predictive markers are needed. To evaluate the role of pretransplant BKPyV-specific antibody, 210 kidney transplant recipients and 130 donors were screened for BKPyV DNA and BKPyV-specific antibodies. We found that the donor BKPyV immunoglobulin G (IgG) seroprevalence and antibody level were strongly associated with BKPyV-DNAemia and BKPyVAN, although multivariant analysis found the presence of anti-BKPyV-specific antibodies as a predictive factor only for BKPyV-DNAemia. The pretransplant recipient status had no effect on posttransplant BKPyV-DNAemia and BKVAN. BKPyV IgG levels remained stable in BKPyV-negative recipients during 1-year follow-up, while a considerable increase was observed in BKPyV-positive patients. The presence of anti-BKPyV-specific antibodies in kidney allograft donors is a good and reliable predictive marker for posttransplant BKPyV replication with relevance to risk stratification in transplant recipients.

650    12

$a virus BK $7 D001739

650    _2

$a lidé $7 D006801

650    _2

$a imunoglobulin G $7 D007074

650    12

$a transplantace ledvin $x škodlivé účinky $7 D016030

650    12

$a intersticiální nefritida $x komplikace $7 D009395

650    12

$a polyomavirové infekce $7 D027601

650    _2

$a séroepidemiologické studie $7 D016036

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Ludvíková, Viera $u National Reference Laboratory for Papillomaviruses and Polyomaviruses, Institute of Hematology and Blood Transfusion, Prague, Czechia

700    1_

$a Hamšíková, Eva $u National Reference Laboratory for Papillomaviruses and Polyomaviruses, Institute of Hematology and Blood Transfusion, Prague, Czechia

700    1_

$a Kolářová, Marie $u Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia

700    1_

$a Šroller, Vojtěch $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czechia

700    1_

$a Viklický, Ondřej $u Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia

700    1_

$a Wohlfahrtová, Mariana $u Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia

773    0_

$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 13, č. - (2022), s. 929946

856    41

$u https://pubmed.ncbi.nlm.nih.gov/35967393 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20221017 $b ABA008

991    __

$a 20221031100528 $b ABA008

999    __

$a ok $b bmc $g 1854724 $s 1176451

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2022 $b 13 $c - $d 929946 $e 20220725 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405

LZP    __

$a Pubmed-20221017